| Particulars |
|
|
|
| Company Name
| Balaxi Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
11.04 |
B.V. (₹) |
23.20 |
| Sales(₹ Cr.) |
60.99 |
NP (₹ Cr.) |
3.60 |
| NP Var (%) |
-2.00 |
Div% |
0.00 |
| CPS(₹) |
0.70 |
EPS (₹) |
0.70 |
| Traded Value(₹ Lakhs) |
0.00 |
52 Week High |
127.00 |
| 52 Week Low |
43.00 |
Price BSE |
0.00 |
| Price NSE |
46.00 |
Market Capital (₹ Cr.) |
253.13 |
| P/C Ratio |
62.60 |
P/E Ratio |
70.50 |
| Price Vs.BV |
1.98 |
|
| Latest Quarter |
| Year End |
202506 |
Sales (₹ Cr.) |
16.71 |
| NP(₹ Cr.) |
0.19 |
NP Var % |
-86.00 |
| Trailing Twelve Months |
| Year End |
202506 |
Sales |
0.00 |
| OPM |
0.00 |
NP |
0.00 |
| NP Var (%) |
-2.04 |
EPS |
0.44 |
| PE |
104.20 |
|
|